Literature DB >> 11134258

Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus.

Mona F Melhem1, Patricia A Craven2, Frederick R Derubertis2.   

Abstract

Antioxidants, in particular vitamin E (VE), have been reported to protect against diabetic renal injury. alpha-Lipoic acid (LA) has been found to attenuate diabetic peripheral neuropathy, but its effects on nephropathy have not been examined. In the present study, parameters of glomerular injury were examined in streptozotocin diabetic rats after 2 mo on unsupplemented diets and in diabetic rats that received the lowest daily dose of dietary LA (30 mg/kg body wt), VE (100 IU/kg body wt), or vitamin C (VC; 1 g/kg body wt), which detectably increased the renal cortical content of each antioxidant. Blood glucose values did not differ among the diabetic groups. At 2 mo, inulin clearance, urinary albumin excretion, fractional albumin clearance, glomerular volume, and glomerular content of immunoreactive transforming growth factor-beta (TGF-beta) and collagen alpha1 (IV) all were significantly increased in unsupplemented D compared with age-matched nondiabetic controls. With the exception of inulin clearance, LA prevented or significantly attenuated the increase in all of these glomerular parameters in D, as well as the increases in renal tubular cell TGF-beta seen in D. At the dose used, VE reduced inulin clearance in D to control levels but failed to alter any of the other indices of glomerular injury or to suppress renal tubular cell TGF-beta in D. VC suppressed urinary albumin excretion, fractional albumin clearance, and glomerular volume but not glomerular or tubular TGF-beta or glomerular collagen alpha1 (IV) content. LA but not VE or VC significantly increased renal cortical glutathione content in D. These data indicate that LA is effective in the prevention of early diabetic glomerular injury and suggest that this agent may have advantages over high doses of either VE or VC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134258     DOI: 10.1681/ASN.V121124

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

1.  Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.

Authors:  Viktor R Drel; Pal Pacher; Martin J Stevens; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2006-01-31       Impact factor: 7.376

2.  The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats.

Authors:  Lina Wu; Yinghui Zhang; Xiaokun Ma; Na Zhang; Guijun Qin
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

3.  Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice.

Authors:  Ekhlas H Abdel-Hafeez; Azza K Ahmad; Ahlam M Abdulla; Soha Aabdel-Wahab; Fadia A Mosalem
Journal:  Parasitol Res       Date:  2012-03-08       Impact factor: 2.289

4.  α-Lipoic acid protects mitochondrial enzymes and attenuates lipopolysaccharide-induced hypothermia in mice.

Authors:  Sylvia Hiller; Robert DeKroon; Longquan Xu; Jennifer Robinette; Witold Winnik; Oscar Alzate; Stephen Simington; Nobuyo Maeda; Xianwen Yi
Journal:  Free Radic Biol Med       Date:  2014-03-24       Impact factor: 7.376

5.  The protective effect of α-Lipoic acid on mitochondria in the kidney of diabetic rats.

Authors:  Li Wang; Chen-Guang Wu; Chun-Qian Fang; Jing Gao; Ying-Zhao Liu; Yan Chen; Yu-Ning Chen; Zhi-Gang Xu
Journal:  Int J Clin Exp Med       Date:  2013-01-26

Review 6.  Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species.

Authors:  Catharine I Whiteside
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 7.  Oxidative stress in diabetic nephropathy: basic and clinical information.

Authors:  H Ha; H B Lee
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

8.  Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.

Authors:  Hanna Shevalye; Roman Stavniichuk; Weizheng Xu; Jie Zhang; Sergey Lupachyk; Yury Maksimchyk; Viktor R Drel; Elizabeth Z Floyd; Barbara Slusher; Irina G Obrosova
Journal:  Biochem Pharmacol       Date:  2009-11-27       Impact factor: 5.858

9.  Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.

Authors:  Viktor R Drel; Weizheng Xu; Jie Zhang; Ivan A Pavlov; Hanna Shevalye; Barbara Slusher; Irina G Obrosova
Journal:  Endocrinology       Date:  2009-10-23       Impact factor: 4.736

10.  Blockade of oxidative stress by vitamin C ameliorates albuminuria and renal sclerosis in experimental diabetic rats.

Authors:  Eun Young Lee; Mi Young Lee; Soon Won Hong; Choon Hee Chung; Sae Yong Hong
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.